This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Styrenic Block Copolymers (SBC) Plastics Demand For Medical Applications Is Expected To Reach USD 698.8 Million In 2018: Transparency Market Research

NEW YORK, March 5, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( http://www.transparencymarketresearch.com) " Styrenic Block Copolymers (SEBS, SBS, SIBS) Plastics Market for Medical Applications (Medical Bags, Tubing, Wound Care, Equipments, Packaging & Diagnostic Products) - Global Industry Analysis, Size, Share, Growth and Forecast, 2012 - 2018," the global SBC demand for medical and healthcare applications was estimated at 123.4 kilo tons in 2011 and is expected to reach 177.1 kilo tons by 2018, growing at a CAGR of 5.4% from 2012 to 2018. In terms of revenues, the market is expected to reach USD 698.8 million by 2018, growing at a CAGR of 7.2% from 2012 to 2018.

Browse the full report at  http://www.transparencymarketresearch.com/styrenic-block-copolymers.html

Demand for SBCs in the medical industry is primarily driven by a growing trend of replacing PVC products by SBCs, primarily due to health and environmental issues related with PVC usage. However, volatility in raw material prices has emerged as a critical challenge to SBC producers worldwide. Increasing R&D in bio-based SBC plastics is expected to herald the most promising opportunity in the market; bio-based SBCs along with being environment friendly are also economically feasible against their synthetic counterparts.

Styrene Ethylene Butylene Styrene (SEBS) is the most dominant SBC product consumed by the medical and healthcare industry and accounted for over 68% of total medical SBC volumes in 2011. SEBS is primarily used for manufacturing medical bags (including IV, CAPD and blood bags) and other flexible materials in the medical industry. SEBS is also the fastest growing type of SBC used in the medical sector.

Related & Recently Published Reports by Transparency Market Research

http://www.transparencymarketresearch.com/acrylonitrile-butadiene-styrene.html

http://www.transparencymarketresearch.com/global-refinery-catalyst-market.html

http://www.transparencymarketresearch.com/sorbitol-market.html

http://www.transparencymarketresearch.com/us-specialty-printing-consumables.html

http://www.transparencymarketresearch.com/group-iv-v-lubricants.html

North America is the leading consumer for medical SBCs and accounted for 38.7% of the global demand in 2011, it is followed by Europe as the second-largest consumer. The growth in North America is primarily driven by the increasing medical expenditure by the federal government in the U.S. Asia Pacific is the fastest growing market for SBCs, and is expected to grow at a CAGR of 7.2% from 2012 to 2018.

Some of the leading companies operating in the global market include Sinopec, Kraton, LCY Chemical, Dynasol, TSRC, LG Chemicals, PolyOne Corporation and so on. Major medical device manufacturers in the market include big multinational companies such as Johnson & Johnson, Siemens Healthcare, GE Healthcare, Baxter International, Medtronic, Covidien and so on.  

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,828.24 +0.49 0.00%
S&P 500 2,067.56 -5.27 -0.25%
NASDAQ 4,791.63 +4.3130 0.09%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs